How to Buy Verona Pharma Stock
Verona Pharma PLC
Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs.
Verona Pharma stock last closed at $92.20, down 0.32% from the previous day, and has increased 492.54% in one year. It has overperformed other stocks in the Biotechnology industry by 5.69 percentage points. Verona Pharma stock is currently +552.05% from its 52-week low of $14.14, and -1.64% from its 52-week high of $93.74.
There are currently 681.06M VRNA shares outstanding. The market value of VRNA is $7.85B. In the last 24 hours, 754,000 VRNA shares were traded.
How to Buy Verona Pharma Stock
Wondering how to invest in Verona Pharma stock? Here's how.
- Choose where to buy Verona Pharma stock: You need to choose an online brokerage, but don't worry - we've sifted through dozens of online brokerages and apps to help you choose where to buy Verona Pharma stock.
- Create a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
- Deposit money your brokerage account: Pick your payment method and add your information.
- Research Verona Pharma stock: The Verona Pharma ticker symbol is VRNA. Is Verona Pharma stock a good investment? Should you buy shares of VRNA? How do VRNA's underlying business fundamentals look? Do top analysts think Verona Pharma is a good buy? Why has VRNA's stock price moved recently? (Hint: Our stock market analysis tools can help you understand if VRNA is a good stock to buy).
- Execute your VRNA purchase: Decide if you will purchase VRNA shares at the current market price or use a limit order to purchase VRNA shares at a particular price.
- Watch your VRNA investment: Create a watchlist to key updates about your position in Verona Pharma stock.
Step 1: Choose where to buy Verona Pharma stock
You will need an online brokerage account to access the NASDAQ market and buy VRNA shares.
Our favorite brokerage: eToro
Based on our research, eToro is the best online stock brokerage. Here's why:
- You can invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
- Access to global financial markets: From Technology to Real Estate, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's top stock exchanges.
- Social investing: eToro boasts a community of more than 20 million users globally. Talk to, learn from, and copy the crypto trades of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your share purchase by signing up for an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Create a brokerage account
Now that you've selected the right brokerage, the next step is to fill out some personal information so you are able to invest in VRNA today.
How to Start a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal data to start your new brokerage account.
- Send your information by clicking the "Create Account" button. Get started with eToro today
Step 3: Deposit money your brokerage account
Now that you've finished signing up on our top ranked stock market app, your next step is to transfer the money for your investment:
Watch the walkthrough below to see the process of transferring funds into your investment account.
Step 4: Research Verona Pharma stock
Once you have chosen the best place to buy Verona Pharma stock, it's very important to evaluate their stock before you buy, so you actually understand the risk and upside.
Verona Pharma stock at a glance
Verona Pharma Due Diligence Score
WallStreetZen was created to help average investors do more accurate fundamental analysis.
You can view all of the due diligence checks on VRNA's stock page.
Is VRNA stock overvalued?
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge VRNA's intrinsic value.
Using relative valuations methods:
- VRNA may be overvalued based on its P/B ratio of 34.64x, relative to Biotechnology industry P/B ratio of 4.66x
You can do additional valuation research on VRNA's stock here.
VRNA Financial Summary
Passed Financial Due Diligence Checks:
- There are more short-term assets than long-term liabilities on the VRNA balance sheet.
- VRNA has $401.42M in cash and short term investments. This is sufficient to cover its annual cash burn of $121.25M.
- There are more short-term assets than short-term liabilities on the VRNA balance sheet.
- VRNA has cash burn of 121253000. It has enough cash and short-term investments to cover this for at least one year.
Failed Financial Due Diligence Checks:
- VRNA has a relatively high debt to equity ratio of 1.32.
- VRNA profit margin has gone down from N/A to -138.3% in the past year.
- Total VRNA debt is higher than 5 years ago, relative to shareholder equity.
Is VRNA stock a Buy, Hold, or Sell, according to Wall Street analysts?
Out of 7 sell side analysts who give ratings on VRNA, the consensus analyst rating on Verona Pharma is a Strong Buy
Please keep in mind that analyst ratings are not stock recommendations, nor are they investment advice.
Latest VRNA Analyst Recommendations
Boobalan Pachaiyappan, a top 33% analyst from Roth MKM initiates coverage on VRNA with a strong buy rating and announces their VRNA price target of $68.00, on Jan 10, 2025.
Joon Lee, a top 2% analyst from Truist Securities reiterates VRNA with a strong buy rating and raises their VRNA price target from $44.00 to $57.00, on Jan 8, 2025.
Truist Securities's Joon Lee raised their price target on Verona Pharma (NASDAQ: VRNA) by 29.5% from $44 to $57 on 2025/01/08. The analyst reiterated their Strong Buy rating on the stock.
Lee attributed their price target hike to Verona Pharma's "positive" Q4 2024 revenue pre-announcement that highlighted "strong" Ohtuvayre* sales.
Over 3.5K unique prescribers wrote more than 16K prescriptions since the drug's launch across a broad COPD demographic, the analyst detailed.
Looking ahead, Lee said the results bode well for robust penetration into about 4.3M persistently symptomatic COPD patients in the U.S. who may benefit from the addition of Ohtuvayre to standard care.
Footnotes
* Ohtuvayre (ensifentrine) is a maintenance treatment for chronic obstructive pulmonary disease (COPD).
You can dig deeper into what analysts are projecting on the Verona Pharma stock forecast page.
VRNA Technical Indicators
Is VRNA Growing Revenue?
Last year, VRNA revenue was $118.54M. Over the last 3 year, VRNA's revenue has gone up by 125.22% per year. This was faster than the Biotechnology industry average of 43.24%.
You can analyze VRNA's earnings and revenue performance here.
Are VRNA executives and large shareholders buying or selling the stock?
In the last 12 months, insiders at VRNA have sold more shares than they have bought.
Mark W. Hahn, Chief Financial Officer of VRNA, was the latest VRNA insider to sell. They sold $4,560,400.00 worth of VRNA shares on Jun 11, 2025.
Learn more about who owns VRNA shares here.
Does VRNA provide a stable income stream?
No, Verona Pharma doesn't provide an income stream by paying out dividends.
VRNA Social Trading Data
One of the biggest reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to learn what other investors have to say.
Step 5: Execute your VRNA purchase
There are two primary order types:
- Market order: A market order is an order to buy or sell a stock at the best possible price.
Market orders are usually the easiest way to buy. - Limit order: A limit order allows you to buy or sell a stock at a specific price (or better).
If you want to be sure you're buying or selling at a given dollar amount limit, place a limit order.
Press the Open Trade button and eToro will place your order.
If you need additional info about buying stocks on eToro, watch the how to video below:
Step 6: Watch your VRNA investment
Now that you own some shares in VRNA, you'll want to keep up with your stock purchase.
Make a watchlist to keep tabs on your VRNA stock.
VRNA Feed
How to Buy Stock in Verona Pharma
To reiterate, here are the 6 steps to buy Verona Pharma stock:
- Choose where to buy Verona Pharma stock
- Create a brokerage account
- Deposit money your brokerage account
- Research Verona Pharma stock
- Execute your VRNA purchase
- Watch your VRNA investment
If you require a online brokerage, eToro is our favorite venue.
Get Started with eToro TodayIf you would like to monitor your investment in Verona Pharma, add VRNA to your watchlist below.
Trending Articles
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.